Corpus Intelligence DCF — NEOSHO MEMORIAL REGIONAL MED CTR 2026-04-26 02:15 UTC
DCF — NEOSHO MEMORIAL REGIONAL MED CTR
Enterprise Value: $-107.5M
🛡️ Public data only — no PHI permitted on this instance.
$-107.5M
Enterprise Value
$-33.6M
PV of Cash Flows
$-73.9M
PV of Terminal Value
$-119.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$55.4M$-6.9M-12.0%$-9.3M$-8.4M
Year 2$57.1M$-6.6M-11.0%$-9.0M$-7.4M
Year 3$58.8M$-6.2M-10.0%$-8.6M$-6.5M
Year 4$60.6M$-6.0M-10.0%$-8.6M$-5.9M
Year 5$62.4M$-6.1M-10.0%$-8.7M$-5.4M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-107.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$53.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1297665878080986
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5